Focused on One Mission. Committed to Long-Term Value.
Minnesota Medical Technologies Corporation is a privately held Delaware C Corporation dedicated to building long-term value through the successful commercialization of innovative medical technologies. Backed by a broad shareholder base and governed by experienced leadership, the company is currently focused on one opportunity: establishing StaySure® as the leading non-surgical treatment option for accidental bowel leakage and fecal incontinence.
Our mission is straightforward: bring StaySure® to the clinicians, healthcare providers, facilities, and patients who need it through a disciplined commercial strategy grounded in clinical evidence, physician education, patient engagement, operational excellence, and broad market access.
With successful commercial operations established in both the United States and Europe, the company has entered an important phase focused on accelerating adoption, expanding patient access, strengthening reimbursement, and creating long-term shareholder value.
We believe sustained success comes from maintaining focus, executing with discipline, and earning the confidence of clinicians, patients, commercial partners, and investors.
Focused on One Solution. Executing with Discipline. Building Long-Term Value.
Investment Highlights
Commercial-Stage Medical Device Company
StaySure® has successfully progressed from concept through product development, clinical validation, regulatory clearance, manufacturing, and commercial launch. Today, our focus is executing a scalable commercial strategy that expands adoption while building long-term enterprise value.
Significant Market Opportunity
Millions of people experience accidental bowel leakage and fecal incontinence, yet many continue to rely on absorbent products or remain untreated. StaySure® addresses this underserved market with a differentiated, non-surgical treatment option designed for independent use or alongside other conservative or advanced therapies.
Clinically Supported Technology
StaySure® is supported by clinical evidence demonstrating its safety and effectiveness, providing physicians with confidence and patients with an important new treatment option.
Multi-Channel Commercial Strategy
Our commercialization strategy is designed to reach patients wherever they enter the healthcare journey. We are expanding adoption through physician education, clinical advocacy, reimbursement initiatives, direct healthcare provider and facility relationships, distribution partnerships, digital patient engagement, and direct-to-consumer programs. By pursuing multiple complementary commercial channels, we are focused on increasing patient access while building a scalable, sustainable business.
Intellectual Property
Our intellectual property portfolio protects the technology behind StaySure® and supports our long-term competitive position.
Experienced Leadership
Our leadership team brings extensive experience across medical devices, regulatory affairs, quality systems, manufacturing, commercialization, reimbursement, healthcare operations, and corporate growth.
Commercial Execution
StaySure® has successfully transitioned from development-stage technology to a commercial medical device supported by clinical evidence, regulatory clearance, established manufacturing, and active commercialization.
Today, Minnesota Medical Technologies is executing a comprehensive commercialization strategy designed to make StaySure® available wherever patients and healthcare providers prefer to access care. Our efforts include:
- Physician education and clinical training
- Peer-to-peer clinical advocacy
- Direct physician prescribing
- Direct relationships with healthcare facilities
- Distribution partnerships
- Digital patient education and awareness
- Direct-to-consumer outreach and eCommerce
- Reimbursement initiatives to improve patient access
- Dedicated customer care supporting both clinicians and patients
Our objective is simple: ensure StaySure® is available through every appropriate commercial channel while maintaining the clinical excellence, product quality, and customer support that define our company.
As physician awareness grows and patient access continues to expand, we believe this diversified commercial approach positions the company for scalable, sustainable growth.
Our Strategy
Our strategy is intentionally focused.
Expand Clinical Adoption
Increase physician awareness through education, clinical evidence, peer-to-peer engagement, and ongoing collaboration with healthcare professionals.
Expand Patient Access
Advance reimbursement initiatives while improving patient access through physician prescribing, healthcare facilities, commercial partners, digital engagement, and direct-to-consumer programs.
Execute Commercial Growth
Continue investing in commercial infrastructure, customer care, manufacturing, distribution, and operational capabilities to support increasing demand across multiple sales channels.
Build a Strong Foundation
Invest in the people, systems, and operational excellence necessary to support sustainable long-term growth while remaining focused on successful execution.
Why We Believe We Are Positioned for Success
Focused Execution
Our organization is dedicated to one commercial opportunity, allowing resources, expertise, and investment to remain aligned around a clear strategic objective.
Compelling Clinical Need
Millions of people living with accidental bowel leakage and fecal incontinence continue to rely on absorbent products or remain untreated, creating a significant opportunity to improve quality of life through innovation.
Differentiated Technology
StaySure® provides a unique, regulatory-cleared, non-surgical treatment option available in both the United States and Europe, supported by published clinical evidence and designed for comfortable, independent use.
Broad Commercialization Strategy
We are pursuing physician education, healthcare facilities, distribution partnerships, digital engagement, reimbursement initiatives, and direct-to-consumer programs to maximize patient access and accelerate adoption.
Scalable Foundation
Established manufacturing, quality systems, regulatory infrastructure, intellectual property, and customer care provide the operational platform necessary to support long-term commercial growth.
Corporate Milestones
Company Formation
Established Minnesota Medical Technologies with the corporate, operational, quality, regulatory, intellectual property, and manufacturing foundation necessary to develop and commercialize innovative medical technologies.
Clinical Validation
Physician collaboration, product refinement, clinical evaluation, and regulatory preparation.
Regulatory Clearance
Regulatory clearance in key global markets, including the United States and Europe, with manufacturing scaled to support commercial growth.
Commercial Launch
Successfully commercialized StaySure® in the United States while supporting commercial operations in Europe through our long-standing distribution partnership.
Commercial Growth
Building upon successful commercial operations in the United States and Europe, our current focus is accelerating physician adoption, expanding patient access through multiple commercial channels, strengthening reimbursement, and scaling commercial operations to support long-term growth.
Our Commitment to Investors
Minnesota Medical Technologies is committed to creating long-term shareholder value through disciplined execution.
Our strategy is intentionally focused. Rather than pursuing multiple products or therapeutic areas simultaneously, we are dedicating our resources to establishing StaySure as the leading non-surgical treatment option for accidental bowel leakage and fecal incontinence.
We believe lasting value is created by combining strong clinical evidence with operational excellence and broad commercial execution. By expanding physician adoption, increasing patient awareness, strengthening reimbursement, and making StaySure® available through every appropriate commercial channel, including healthcare providers, facilities, distribution partners, and direct-to-consumer engagement, we are building a company positioned for sustainable long-term growth.
We remain committed to transparent communication, responsible stewardship, and disciplined execution as we continue to grow Minnesota Medical Technologies.
Investor Contact
Minnesota Medical Technologies welcomes inquiries from institutional investors, strategic partners, family offices, and qualified accredited investors interested in learning more about our company.
For additional information regarding investment opportunities or corporate initiatives, please contact:
Investor Relations
Minnesota Medical Technologies Corporation
Email: lmboe@mnmedicaltechnologies.com
Phone: 507-533-0366
2446 Henry Road NW
Stewartville, MN 55976